Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of genetically engineered bacterium producing lincomycin and its construction method and application

A genetically engineered bacteria and lincomycin-producing technology are applied in the field of genetic engineering to achieve the effects of simple construction methods, good industrial application value, and increased industrial output

Active Publication Date: 2021-05-25
EAST CHINA UNIV OF SCI & TECH
View PDF13 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there is no case of improving lincomycin production by modifying Xre family genes

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of genetically engineered bacterium producing lincomycin and its construction method and application
  • A kind of genetically engineered bacterium producing lincomycin and its construction method and application
  • A kind of genetically engineered bacterium producing lincomycin and its construction method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0126] Example 1 Construction of slinc566, slinc4481, slinc6027, slinc6156, slinc348, slinc4742 knockout vectors

[0127] The gene knockout scheme in this example is based on CRISPR / Cas9 technology.

[0128] The PCR reaction conditions of this embodiment are: 98°C, 10 minutes; (98°C, 40 seconds; 64°C, 30 seconds; 72°C, 80 seconds) × 30 cycles; 72°C, 10 minutes; 25°C, 2 minutes .

[0129] 1. Construction of slinc566 knockout vector

[0130] Step 1: Using u566-F / R and d566-F / R as primers and Streptomyces lincolnensis NRRL 2936 genome as a template, PCR amplifies the upstream and downstream homology arms of slinc566. After detection by 1% agarose gel electrophoresis, the target band at 1.1 kb was cut and purified.

[0131] Step 2: Use the upstream and downstream homology arm fragments obtained in the previous PCR reaction as templates, and use sg566 / u566-R as primers to amplify by PCR to add the sgRNA sequence that specifically recognizes the sequence within the slinc566 gene....

Embodiment 2

[0143] Example 2 Gene knockout of slinc566, slinc4481, slinc6027, slinc6156, slinc348, and slinc4742.

[0144] The PCR reaction conditions of this embodiment are: 98°C, 10 minutes; (98°C, 40 seconds; 64°C, 30 seconds; 72°C, 80 seconds) × 30 cycles; 72°C, 10 minutes; 25°C, 2 minutes .

[0145] 1. The principle of slinc566 gene knockout of the present invention is as follows: Figure 7 shown.

[0146] Step 1, transforming the pKCcas9d566 plasmid into Escherichia coli S17-1. Cultured in LB medium to OD 600 =0.4 pKCcas9d566 / S17-1 and Streptomyces lincolnensis NRRL2936 cultured in YEME medium until the hyphae were uniform and dense, collected by centrifugation and washed, resuspended in 2×YT medium, and spread on ISP4 medium together, at 28°C Cultured for conjugative transfer. After 18 hours of plate coating, 1 mL of sterile aqueous solution containing apramycin (Apramycin, 20 μg / mL) and nalidixic acid (Nalidixic acid, 25 μg / mL) was covered for screening. After continuing to ...

Embodiment 3

[0163] Example 3 Construction of genetically engineered bacteria Δ4481Δ6156

[0164] The PCR reaction conditions of this embodiment are the same as that of embodiment 2.

[0165] Step 1: The pKCcas9d6156 plasmid was transformed into Escherichia coli S17-1. Cultured in LB medium to OD 600 =0.4 pKCcas9d6156 / S17-1 and the genetically engineered strain Δ4481 that was cultured in YEME medium until the hyphae were uniform and dense, collected by centrifugation and washed, resuspended in 2×YT medium, and spread on ISP4 medium together, at 28°C Cultured for conjugative transfer. After 18 hours of plate coating, 1 mL of sterile aqueous solution containing apramycin (Apramycin, 20 μg / mL) and nalidixic acid (Nalidixic acid, 25 μg / mL) was covered for screening. After continuing to culture at 28°C for 4-7 days, colonies of transformants can grow. Pick 10 transformant mycelia and transfer them to MS medium containing 20 μg / μL apramycin, continue culturing at 28°C for 3-5 days, then inoc...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a genetically engineered bacterium producing lincomycin, which is to knock out the gene encoding the protein containing the TPR domain of Streptomyces lincoln and knock out the gene encoding RNase and overexpress the code of Streptomyces lincoln. The gene construction of Xre family protein was obtained. The invention also discloses a method for constructing a lincomycin-producing genetically engineered bacterium, which takes Streptomyces lincoln as the starting strain, knocks out the gene encoding the protein containing the TPR domain of Streptomyces lincoln and converts the gene encoding the RNase Knockout the gene of Streptomyces lincolinus and overexpress the gene encoding Xre family protein to obtain the genetically engineered bacteria producing lincomycin. The method for constructing lincomycin-producing genetically engineered bacteria of the present invention is simple and convenient to operate, and the constructed genetically engineered bacteria can increase the yield of lincomycin, and has good application prospects.

Description

technical field [0001] The invention belongs to the field of genetic engineering, and in particular relates to a genetically engineered bacterium producing lincomycin and its construction method and application. Background technique [0002] Lincomycin is a lincosamide antibiotic produced by Streptomyces lincolnensis with wide clinical value. Lincomycin and its derivatives (such as the chlorinated derivative clindamycin) have inhibitory effects on anaerobic Gram-positive bacteria and protozoa. Lincomycin inhibits the transfer of polypeptide chains during protein translation by hydrophobically binding to the central loop of 23s rRNA in the 50s subunit of ribosomes, thereby exerting its antibacterial function. Lincomycin does not have cross-resistance to most pharmaceutical antibiotics, and is widely used clinically in the treatment of respiratory tract, urinary system, skin and soft tissue infections, chronic osteomyelitis, meningitis, otitis media and eye diseases, etc., es...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N1/21C12N15/76C12N15/90C12N15/55C12N15/31C12R1/565
CPCC07K14/36C12N9/22C12N15/76C12N15/902
Inventor 吴海珍叶江张惠展侯兵兵王瑞达
Owner EAST CHINA UNIV OF SCI & TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com